SPY384.24+0.35 0.09%
DIA311.87+0.10 0.03%
IXIC13,530.92+73.67 0.55%

JP Morgan Upgrades Vir Biotechnology to Neutral, Lowers Price Target to $29

JP Morgan upgrades Vir Biotechnology (NASDAQ:VIR) from Underweight to Neutral and lowers the price target from $30 to $29.

· 09/11/2020 12:03
JP Morgan upgrades Vir Biotechnology (NASDAQ:VIR) from Underweight to Neutral and lowers the price target from $30 to $29.